210 related articles for article (PubMed ID: 2990275)
1. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.
Jaffe HW; Darrow WW; Echenberg DF; O'Malley PM; Getchell JP; Kalyanaraman VS; Byers RH; Drennan DP; Braff EH; Curran JW
Ann Intern Med; 1985 Aug; 103(2):210-4. PubMed ID: 2990275
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
[TBL] [Abstract][Full Text] [Related]
4. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
6. Unexplained lymphadenopathy in homosexual men. A longitudinal study.
Fishbein DB; Kaplan JE; Spira TJ; Miller B; Schonberger LB; Pinsky PF; Getchell JP; Kalyanaraman VS; Braude JS
JAMA; 1985 Aug; 254(7):930-5. PubMed ID: 2991618
[TBL] [Abstract][Full Text] [Related]
7. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
[TBL] [Abstract][Full Text] [Related]
8. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
[TBL] [Abstract][Full Text] [Related]
10. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
11. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
[TBL] [Abstract][Full Text] [Related]
12. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London.
Gazzard BG; Shanson DC; Farthing C; Lawrence AG; Tedder RS; Cheingsong-Popov R; Dalgleish A; Weiss RA
Lancet; 1984 Sep; 2(8401):480-3. PubMed ID: 6147547
[TBL] [Abstract][Full Text] [Related]
13. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
[TBL] [Abstract][Full Text] [Related]
14. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.
Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH
Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805
[TBL] [Abstract][Full Text] [Related]
15. The AIDS epidemic.
Landesman SH; Ginzburg HM; Weiss SH
N Engl J Med; 1985 Feb; 312(8):521-5. PubMed ID: 2982097
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome.
Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ
Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
[TBL] [Abstract][Full Text] [Related]
19. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.
Dobozin BS; Judson FN; Cohn DL; Penley KA; Rickmann PE; Blaser MJ; Sarin PS; Weiss SH; Kirkpatrick CH
Cell Immunol; 1986 Mar; 98(1):156-71. PubMed ID: 3017581
[TBL] [Abstract][Full Text] [Related]
20. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]